Moustapha El-Amine

Moustapha El-AmineSr. Director, Scientific Services, Emergent BioSolutions

Moustapha El-Amine is a Senior Director and the Head of the Scientific Services (Affairs) department at Emergent Biosolutions Inc.  His role is to lead and manage technical due diligence activities associated with merger and new product acquisition activities and to develop corporate processes to evaluate internal preclinical and research programs in oncology, autoimmunity and infectious diseases.  He also assesses the development status and scientific progress of all preclinical and research programs in all platforms at Emergent BioSolutions.  In his role Dr. El-Amine continuously monitors and evaluates new technologies and selects those that are of interest to Emergent Biosolutions.  Before Joining Emergent Dr. El-Amine was a Principal Investigator at Dynport Vaccines (DVC, Inc.) leading a Vaccine program for DoD and before that he lead the iLT patch vaccine program at Iomai corp (Later Acquired by Intercell).  Dr. El-Amine has a Bachelor degree in Biology from the American University of Beirut (AUB, Beirut, Lebanon), a Masters in Molecular Endocrinology from Laval University (Quebec, Canada) and a PhD in Cell biology (Immunology) from Sherbrooke University (Sherbrooke, Canada).  Dr. El-Amine moved from Canada to Rockville, Maryland in 1997 to pursue postdoctoral training in gene-therapy/immunology at the American Red Cross, Jerome Holland Laboratories in David Scott’s Lab.  Dr. El-Amine is completing an MBA at the Carey School of Business at Johns Hopkins University.